# K023573: Wizair Compression System

- Pathway: 510(k) (Special)
- Applicant: Medical Compression Systems (Dbn), Ltd.
- Decided: Nov 21, 2002 after 28 days
- Product code: JOW (Sleeve, Limb, Compressible)
- Device class: 2
- Regulation: 21 CFR 870.5800
- Recalls of this device: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
58 later devices descend from it; 5 cite it directly.
0 of 59 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) WizAir DVF3: named in the summary without a submission number

## Most influential descendants
- K061125: Dvtcare CA5 (2006), 30 descendants of its own
- K060146: Activecare ++ System (2006), 30 descendants of its own
- K103187: Tripleplay-VT Vascular Therapy System (2011), 25 descendants of its own
- K133274: Vena Pro (2014), 22 descendants of its own
- K062818: Flexitouch System (2006), 10 descendants of its own

## Recalls of this device
- Aug 28, 2011 · Not classified · Z-0387-2012: This voluntary field action is being undertaken because MCS has received a limited number of reports involving the use of a non-MCS AC/DC adaptor with the ActiveCare DVT and ActiveCare+S.F.T. devices.

## Indications for use
The WizAir DVP R1 is a prescriptive device that induces Continuous Enhanced Circulation Therapy of the lower limbs. The WizAir DVP is intended for use in: Preventing Deep Vein Thrombosis (DIT). Enhancing blood circulation. Diminishing post-operative pain and swelling. Reducing wound-healing time. Treatment and assistance in healing: stasis dermatitis; venous stasis ulcers; arterial and diabetic leg ulcers. Treatment of chronic venous insufficiency. Reducing edema.

Source page: https://510kreport.com/device/K023573
Methodology: https://510kreport.com/methodology